Income Statement (TTM)
Genscript Biotech Corporation Income Statement shows changes in income and expenses over a period of time. Income Statement data includes Sales and Revenue, Gross Profit, Research and Development (R&D), Selling, General and Administrative Expense (SG&A), Operating Income, Income Tax Expense, Interest Expense, Non-Operating Income, Earnings per Share (EPS), and Shares Outstanding.
All numbers are times 1,000,000 except per share units.
|
2020 09-30 |
2020 12-31 |
2021 03-31 |
2021 06-30 |
2021 09-30 |
2021 12-31 |
2022 03-31 |
2022 06-30 |
2022 09-30 |
2022 12-31 |
2023 03-31 |
2023 06-30 |
2023 09-30 |
2023 12-31 |
2024 03-31 |
2024 06-30 |
2024 12-31 |
2025 03-31 |
2025 06-30 |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 354 | 391 | 422 | 454 | 483 | 490 | 530 | 570 | 598 | 626 | 667 | 707 | 773 | 560 | 925 | 1,010 | 594 | 711 | 828 |
| Change (%) | 10.30 | 8.08 | 7.48 | 6.28 | 1.57 | 8.16 | 7.55 | 4.87 | 4.65 | 6.53 | 6.13 | 9.34 | -27.54 | 64.96 | 9.20 | -41.12 | 19.65 | 16.42 | |
| % of Revenue | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
| Cost Of Sales | 122 | 135 | 151 | 168 | 188 | 208 | 233 | 258 | 290 | 322 | 359 | 397 | 413 | 290 | 449 | 468 | 322 | 346 | 369 |
| Change (%) | 10.95 | 12.13 | 10.81 | 11.90 | 10.63 | 12.08 | 10.78 | 12.40 | 11.03 | 11.69 | 10.46 | 4.18 | -29.88 | 54.92 | 4.24 | -31.13 | 7.21 | 6.73 | |
| % of Revenue | 34.32 | 34.53 | 35.82 | 36.93 | 38.88 | 42.35 | 43.89 | 45.20 | 48.45 | 51.40 | 53.89 | 56.09 | 53.44 | 51.71 | 48.57 | 46.37 | 54.23 | 48.59 | 44.54 |
| Gross Operating Profit | 233 | 256 | 271 | 286 | 295 | 283 | 297 | 312 | 308 | 304 | 307 | 311 | 360 | 271 | 476 | 541 | 272 | 366 | 459 |
| Change (%) | 9.95 | 5.95 | 5.61 | 2.99 | -4.20 | 5.29 | 5.02 | -1.33 | -1.35 | 1.08 | 1.07 | 15.92 | -24.84 | 75.71 | 13.87 | -49.75 | 34.38 | 25.59 | |
| % of Revenue | 65.68 | 65.47 | 64.18 | 63.07 | 61.12 | 57.65 | 56.11 | 54.80 | 51.55 | 48.60 | 46.11 | 43.91 | 46.56 | 48.29 | 51.43 | 53.63 | 45.77 | 51.41 | 55.46 |
| SG&A | 171 | 197 | 216 | 235 | 270 | 303 | 330 | 356 | 354 | 352 | 363 | 374 | 383 | 192 | 408 | 424 | 209 | 214 | 220 |
| Change (%) | 14.91 | 9.74 | 8.88 | 14.69 | 12.36 | 8.62 | 7.94 | -0.53 | -0.53 | 3.15 | 3.05 | 2.46 | -49.98 | 112.82 | 3.81 | -50.65 | 2.53 | 2.47 | |
| % of Revenue | 48.39 | 50.41 | 51.19 | 51.85 | 55.96 | 61.91 | 62.17 | 62.39 | 59.18 | 56.25 | 54.47 | 52.89 | 49.56 | 34.21 | 44.14 | 41.96 | 35.17 | 30.13 | 26.52 |
| R&D | 251 | 263 | 293 | 323 | 341 | 358 | 360 | 361 | 375 | 390 | 405 | 420 | 426 | 53 | 447 | 462 | 54 | 57 | 60 |
| Change (%) | 4.93 | 11.33 | 10.18 | 5.47 | 5.18 | 0.35 | 0.34 | 4.05 | 3.89 | 3.81 | 3.67 | 1.55 | -87.64 | 748.92 | 3.25 | -88.35 | 5.96 | 5.63 | |
| % of Revenue | 70.84 | 67.39 | 69.42 | 71.16 | 70.61 | 73.13 | 67.84 | 63.30 | 62.80 | 62.35 | 60.75 | 59.35 | 55.12 | 9.40 | 48.39 | 45.75 | 9.05 | 8.01 | 7.27 |
| OpEx | 544 | 595 | 661 | 726 | 798 | 869 | 922 | 974 | 1,019 | 1,064 | 1,127 | 1,191 | 1,223 | 534 | 1,304 | 1,354 | 585 | 617 | 649 |
| Change (%) | 9.42 | 10.98 | 9.90 | 9.94 | 8.89 | 6.03 | 5.69 | 4.59 | 4.38 | 5.97 | 5.64 | 2.71 | -56.31 | 144.15 | 3.77 | -56.77 | 5.42 | 5.14 | |
| % of Revenue | 153.55 | 152.33 | 156.42 | 159.95 | 165.46 | 177.39 | 173.90 | 170.90 | 170.43 | 170.00 | 169.11 | 168.32 | 158.12 | 95.33 | 141.09 | 134.07 | 98.44 | 86.73 | 78.33 |
| Operating Income | -190 | -205 | -238 | -272 | -316 | -379 | -392 | -404 | -421 | -438 | -461 | -483 | -450 | 26 | -380 | -344 | 9 | 94 | 179 |
| Change (%) | 7.79 | 16.53 | 14.19 | 16.05 | 20.09 | 3.28 | 3.18 | 4.18 | 4.01 | 5.18 | 4.92 | -6.99 | -105.83 | -1,550.30 | -9.45 | -102.70 | 916.52 | 90.16 | |
| % of Revenue | -53.55 | -52.33 | -56.42 | -59.95 | -65.46 | -77.39 | -73.90 | -70.90 | -70.43 | -70.00 | -69.11 | -68.32 | -58.12 | 4.67 | -41.09 | -34.07 | 1.56 | 13.27 | 21.67 |
| Interest Expense | -5 | -1 | -2 | -3 | -5 | -9 | -13 | -18 | -22 | -25 | -6 | -28 | -29 | -8 | -11 | -14 | |||
| Change (%) | -69.87 | 45.44 | 31.24 | 96.17 | 49.02 | 34.52 | 25.66 | 11.33 | -77.02 | 394.71 | 3.10 | -72.56 | 36.93 | 26.97 | |||||
| % of Revenue | -1.33 | -0.36 | -0.49 | -0.65 | -0.80 | -1.49 | -2.12 | -2.68 | -3.17 | -3.23 | -1.02 | -3.07 | -2.90 | -1.35 | -1.55 | -1.69 | |||
| Net Income | -194 | -205 | -194 | -183 | -265 | -359 | -381 | -403 | -315 | -227 | -206 | -185 | -140 | -95 | -136 | -177 | 2,962 | 3,037 | 3,112 |
| Change (%) | 5.75 | -5.36 | -5.66 | 45.06 | 35.15 | 6.19 | 5.83 | -21.86 | -27.98 | -9.24 | -10.18 | -24.18 | -31.90 | 42.70 | 29.92 | -1,773.27 | 2.53 | 2.46 | |
| % of Revenue | -54.69 | -52.44 | -45.91 | -40.30 | -55.00 | -73.19 | -71.85 | -70.70 | -52.68 | -36.26 | -30.89 | -26.14 | -18.13 | -17.03 | -14.74 | -17.53 | 498.22 | 426.93 | 375.74 |
Source: Capital IQ
